TABLE 2.
The IC50, EC50, and CC50 values of cyclopropane-based compounds (C1c/d-C17c/d [40]) against FMDV 3Cpro in the enzyme and cell-based report assays
|
|||||
|---|---|---|---|---|---|
| Compound | R | Z | FRET assay (IC50, µM)a |
Cell-based assay (EC50 µM)b |
CC50 (µM) |
| C1c |
|
-CHO | 1.00 ± 0.28c | 3.15 ± 0.35 | >50 |
| C1d | -CH(OH)SO3Na | 0.75 ± 0.07 | 3.25 ± 0.63 | >50 | |
| C2c |
|
-CHO | 1.35 ± 0.64 | 1.20 ± 0.14 | >50 |
| C2d | -CH(OH)SO3Na | 1.10 ± 0.57 | 1.45 ± 0.21 | >50 | |
| C3c |
|
-CHO | 0.69 ± 0.13 | 2.74 ± 2.14 | >50 |
| C3d | -CH(OH)SO3Na | 0.80 ± 0.14 | 4.02 ± 0.30 | >50 | |
| C4c |
|
-CHO | 0.82 ± 0.15 | 2.74 ± 2.14 | >50 |
| C4d | -CH(OH)SO3Na | 1.35 ± 0.35 | 3.65 ± 0.63 | >50 | |
| C5c |
|
-CHO | 1.05 ± 0.21 | 2.13 ± 0.49 | >50 |
| C5d | -CH(OH)SO3Na | 0.95 ± 0.22 | 1.89 ± 0.09 | >50 | |
| C6c |
|
-CHO | 0.80 ± 0.05 | 3.30 ± 0.71 | >50 |
| C6d | -CH(OH)SO3Na | 0.58 ± 0.11 | 2.85 ± 0.49 | >50 | |
| C7c |
|
-CHO | 0.59 ± 0.04 | 2.00 ± 0.14 | >50 |
| C7d | -CH(OH)SO3Na | 0.75 ± 0.07 | 2.15 ± 0.35 | >50 | |
| C8c |
|
-CHO | 1.15 ± 0.08 | NTd | >50 |
| C8d | -CH(OH)SO3Na | 0.55 ± 0.07 | NT | >50 | |
| C9c |
|
-CHO | 0.75 ± 0.14 | 2.95 ± 0.28 | >50 |
| C9d | -CH(OH)SO3Na | 0.84 ± 0.06 | 2.05 ± 0.64 | >50 | |
| C10c |
|
-CHO | 1.25 ± 0.07 | 3.65 ± 1.48 | >50 |
| C10d | -CH(OH)SO3Na | 1.05 ± 0.21 | 2.85 ± 1.55 | >50 | |
| C11c |
|
-CHO | 0.95 ± 0.21 | 1.08 ± 0.05 | >50 |
| C11d | -CH(OH)SO3Na | 0.45 ± 0.13 | 1.02 ± 0.17 | >50 | |
| C12c |
|
-CHO | 0.50 ± 0.14 | 0.88 ± 0.25 | >50 |
| C12d | -CH(OH)SO3Na | 0.51 ± 0.06 | 1.25 ± 0.07 | >50 | |
| C13c |
|
-CHO | 1.55 ± 0.07 | 2.95 ± 0.21 | >50 |
| C13d | -CH(OH)SO3Na | 0.75 ± 0.07 | 3.10 ± 0.42 | >50 | |
| C14c |
|
-CHO | 0.63 ± 0.10 | 7.05 ± 0.78 | >50 |
| C14d | -CH(OH)SO3Na | 1.05 ± 0.64 | 6.30 ± 0.85 | >50 | |
| C15c |
|
-CHO | 0.38 ± 0.11 | 0.45 ± 0.05 | >50 |
| C15d | -CH(OH)SO3Na | 0.29 ± 0.08 | 0.50 ± 0.11 | >50 | |
| C16c |
|
-CHO | 0.36 ± 0.09 | 0.90 ± 0.06 | >50 |
| C16d | -CH(OH)SO3Na | 0.33 ± 0.04 | 1.21 ± 0.48 | >50 | |
| C17c |
|
-CHO | 0.65 ± 0.07 | >10 | >50 |
| C17d | -CH(OH)SO3Na | 0.75 ± 0.09 | >10 | >50 | |
IC50, 50% inhibitory concentration.
EC50, 50% effective concentration; CC50, 50% cytotoxic concentration (values are M ± SD).
Mean (M) ± standard deviation (SD) of the means.
NT, not tested.